She is currently serving as cofounder and chief of operations, Community & Nutrition at Vineyard, a virtual weight management and cardiometabolic health clinic
GLP-1 (glucagon-like peptide-1) drugs, such as semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound), have shown some weight loss and cardiometabolic benefits in clinical trials
Early appetite changes, fluid shifts, diet patterns, side effects, and medication tolerance can all affect the curve
This is beneficial for most patients but may require adjustment of antihypertensive medications to prevent hypotension
Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels